A hospital data breach, meet Dr. Walmart, and it's eater be eaten in biotech because this is where the money is.

Hi fools, welcome to where the money is. It's the special Wednesday health care edition.

I'm David Williamson and I'm joined by my fellow health care analyst Michael Douglas.

Michael, how are you doing this week?

Fantastic.

Well we have a good show. Yeah. I say that every week, but it we have a good show.

I say that every week, but it is always a good show.

At least we try to that.

We like to think so.

We try for that. It's been pretty busy.

We're going to cover all the hottest headlines in health care.

Make sure our viewers and listeners are up to speed

and they can make, hopefully make some good investment decisions

or at least be the toast of any cocktail party they attend this week.

Maybe near to your cocktail parties, but uh...

You'll be a very interesting person.

Yes, you will.

That's what we're going for at least.

So let's start with our first headline.

It's the eaterater Be Eaton in biotech.

Allergan, this is courtesy of the Wall Street Journal, is seeking to fend off a hostile

bid from valiant pharmaceuticals and hedge funder, Billman and to do that they're looking to buy

...